Xanomeline and its Impurities

Xanomeline, a cholinergic agonist, was initially evaluated for the treatment of Alzheimer’s disease and schizophrenia. Reference standards of Xanomeline API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.